No abstract available
Keywords:
RNA interference; drugs dose reduction; gene targeting; mitogen-activated protein kinase; tumour therapy.
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology*
-
Biomarkers, Tumor / antagonists & inhibitors*
-
Biomarkers, Tumor / genetics
-
Biomarkers, Tumor / metabolism
-
Cell Survival / drug effects
-
Drug Resistance, Neoplasm
-
Humans
-
MAP Kinase Kinase 3 / antagonists & inhibitors*
-
MAP Kinase Kinase 3 / genetics
-
MAP Kinase Kinase 3 / metabolism
-
Molecular Targeted Therapy*
-
Neoplasms / drug therapy*
-
Neoplasms / enzymology
-
Neoplasms / genetics
-
Neoplasms / pathology
-
Protein Kinase Inhibitors / therapeutic use*
-
Signal Transduction / drug effects
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Protein Kinase Inhibitors
-
MAP Kinase Kinase 3
-
MAP2K3 protein, human